961
Views
6
CrossRef citations to date
0
Altmetric
Commentaries

Communication interventions to address COVID-19 vaccine hesitancy in India

Pages 330-337 | Received 18 Jul 2021, Accepted 02 Aug 2021, Published online: 20 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anirudh Tagat, Hansika Kapoor, Varun Arora, Sujoy Chakravarty, Shagata Mukherjee & Shubhabrata Roy. (2023) Double Jab: Survey Evidence on Vaccine Hesitancy, Beliefs, and Attitudes in India. Health Communication 38:8, pages 1697-1708.
Read now
Rupali J. Limaye, Daniel J. Erchick, Kristian Balgobin, Alexandra Michel & Gretchen Schulz. (2022) Message testing in India for COVID-19 vaccine uptake: What appeal and what messenger are most persuasive?. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (3)

Rajkamal Choudhary, Raj Rani Choudhary & Anjum Pervez. (2023) COVID-19 Vaccination and Gaps in India. Cureus.
Crossref
Anirudh Tagat & Hansika Kapoor. (2023) We're very grateful: moral emotions, role models, and trust predict vaccine uptake intent in India. Behavioural Public Policy, pages 1-22.
Crossref
Pritu Dhalaria, Himanshu Arora, Ajeet Kumar Singh, Mansi Mathur & Ajai Kumar S.. (2022) COVID-19 Vaccine Hesitancy and Vaccination Coverage in India: An Exploratory Analysis. Vaccines 10:5, pages 739.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.